Table 2.

Statistics of the 12 patients enrolled with estimation of the risk of recurrences and therapeutic success.

Technical success	100% of the total number of patients (12/12). No peri-procedural complications.
First evaluation performed 48 hours after the procedure	No bleeding relapses in 11 of 12 patients (91,6%). Fatal massive hemoptysis in only one patient (8,3%).
Next three-month follow-up	No relapses on the remaining patients enrolled (11/11).
Next six-month follow-up	1 only patient required a second embolization four months after the first procedure (9,09%). 2 patients didn’t show any recurrence episodes (18,18%). 8 patients documented with relapses of bleeding did not require any trasfusion (72,73%).